Literature DB >> 26477548

Ultraviolet radiation, vitamin D and multiple sclerosis.

Robyn M Lucas1,2, Scott N Byrne3, Jorge Correale4, Susanne Ilschner5, Prue H Hart2.   

Abstract

There is compelling epidemiological evidence that the risk of developing multiple sclerosis is increased in association with low levels of sun exposure, possibly because this is associated with low vitamin D status. Recent work highlights both vitamin D and non-vitamin D effects on cellular immunity that suggests that higher levels of sun exposure and/or vitamin D status are beneficial for both MS risk and in ameliorating disease progression. Here we review this recent evidence, focusing on regulatory cells, dendritic cells, and chemokines and cytokines released from the skin following exposure to ultraviolet radiation.

Entities:  

Keywords:  B regulatory cells; cis-urocanic acid; dendritic cells; multiple sclerosis; ultraviolet radiation; vitamin D

Mesh:

Substances:

Year:  2015        PMID: 26477548     DOI: 10.2217/nmt.15.33

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  21 in total

Review 1.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 2.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

3.  Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Authors:  Sandra Magalhaes; Maura Pugliatti; Trond Riise; Kjell-Morten Myhr; Antonio Ciampi; Kjetil Bjornevik; Christina Wolfson
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

4.  Environmental effects of ozone depletion and its interactions with climate change: Progress report, 2016.

Authors: 
Journal:  Photochem Photobiol Sci       Date:  2017-02-15       Impact factor: 3.982

Review 5.  Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.

Authors:  Manon Galoppin; Saniya Kari; Sasha Soldati; Arindam Pal; Manon Rival; Britta Engelhardt; Anne Astier; Eric Thouvenot
Journal:  Brain Commun       Date:  2022-06-30

6.  Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules.

Authors:  Prue H Hart; Robyn M Lucas; David R Booth; William M Carroll; David Nolan; Judith M Cole; Anderson P Jones; Allan G Kermode
Journal:  Front Immunol       Date:  2017-01-24       Impact factor: 7.561

Review 7.  Gut-CNS-Axis as Possibility to Modulate Inflammatory Disease Activity-Implications for Multiple Sclerosis.

Authors:  Ann-Katrin Fleck; Detlef Schuppan; Heinz Wiendl; Luisa Klotz
Journal:  Int J Mol Sci       Date:  2017-07-14       Impact factor: 5.923

8.  Determining Causation from Observational Studies: A Challenge for Modern Neuroepidemiology.

Authors:  George A Jelinek
Journal:  Front Neurol       Date:  2017-06-01       Impact factor: 4.003

9.  Obesity in Pediatric-Onset Multiple Sclerosis: A French Cohort Study.

Authors:  Pauline Milles; Gianpaolo De Filippo; Hélène Maurey; Thomas Tully; Kumaran Deiva
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-20

Review 10.  Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L.

Authors:  William B Grant; Susan J Whiting; Gerry K Schwalfenberg; Stephen J Genuis; Samantha M Kimball
Journal:  Dermatoendocrinol       Date:  2016-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.